---
input_text: Dermatologic complications in pediatric patients after hematopoietic stem
  cell transplantation for sickle cell disease. Dermatologic complications are common
  following allogeneic hematopoietic stem cell transplantation, but dermatologic complications
  among pediatric patients undergoing hematopoietic stem cell transplantation for
  the treatment of sickle cell disease have been poorly characterized. In this case
  series of 17 patients (<21 years old) with sickle cell disease who underwent hematopoietic
  stem cell transplantation, 16 (94.1%) experienced one or more dermatologic complications
  after transplant, with the most common complications including acute or chronic
  mucocutaneous graft-versus-host disease (GVHD) (34.1% of complications), skin eruptions
  of unknown origin (15.9% of complications), infections (15.9% of complications),
  and chemotherapy-related pigmentary changes (11.4% of complications). Patients who
  developed acute or chronic skin GVHD were significantly older at the time of hematopoietic
  stem cell transplantation. These findings highlight the need to closely monitor
  for dermatologic complications in pediatric patients who undergo hematopoietic stem
  cell transplantation for sickle cell disease and underscore the importance of involving
  dermatology early on when skin complications occur, although further research with
  a larger multicenter study could help clarify the risk for dermatologic complications
  and help identify potential ways to mitigate this risk.
raw_completion_output: |-
  primary_disease: sickle cell disease
  medical_actions: closely monitor for dermatologic complications; involving dermatology early on
  symptoms: acute or chronic mucocutaneous graft-versus-host disease (GVHD); skin eruptions of unknown origin; infections; chemotherapy-related pigmentary changes
  chemicals: 
  action_annotation_relationships: closely monitor for dermatologic complications PREVENTS acute or chronic mucocutaneous graft-versus-host disease (GVHD) IN sickle cell disease; closely monitor for dermatologic complications PREVENTS skin eruptions of unknown origin IN sickle cell disease; closely monitor for dermatologic complications PREVENTS infections IN sickle cell disease; closely monitor for dermatologic complications PREVENTS chemotherapy-related pigmentary changes IN sickle cell disease; involving dermatology early on PREVENTS acute or chronic mucocutaneous graft-versus-host disease (GVHD) IN sickle cell disease; involving dermatology early on PREVENTS skin eruptions of unknown origin IN sickle cell disease; involving dermatology early on PREVENTS infections IN sickle cell disease; involving dermatology early on PREVENTS chemotherapy-related pigmentary changes IN sickle cell disease
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  involving dermatology early on PREVENTS chemotherapy-related pigmentary changes IN sickle cell disease

  ===

extracted_object:
  primary_disease: MONDO:0011382
  medical_actions:
    - closely monitor for dermatologic complications
    - involving dermatology early on
  symptoms:
    - acute or chronic mucocutaneous graft-versus-host disease (GVHD)
    - skin eruptions of unknown origin
    - infections
    - chemotherapy-related pigmentary changes
  action_annotation_relationships:
    - subject: closely monitor for dermatologic complications
      predicate: PREVENTS
      object: acute or chronic mucocutaneous graft-versus-host disease (GVHD)
      qualifier: MONDO:0011382
    - subject: closely monitor for dermatologic complications
      predicate: PREVENTS
      object: skin eruptions of unknown origin
      qualifier: MONDO:0011382
    - subject: closely monitor for dermatologic complications
      predicate: PREVENTS
      object: infections
      qualifier: MONDO:0011382
    - subject: closely monitor for dermatologic complications
      predicate: PREVENTS
      object: chemotherapy-related pigmentary changes
      qualifier: MONDO:0011382
    - subject: involving dermatology early on
      predicate: PREVENTS
      object: acute or chronic mucocutaneous graft-versus-host disease (GVHD)
      qualifier: MONDO:0011382
    - subject: involving dermatology early on
      predicate: PREVENTS
      object: skin eruptions of unknown origin
      qualifier: MONDO:0011382
    - subject: involving dermatology early on
      predicate: PREVENTS
      object: infections
      qualifier: MONDO:0011382
    - subject: involving dermatology early on
      predicate: PREVENTS
      object: chemotherapy-related pigmentary changes
      qualifier: MONDO:0011382
named_entities:
  - id: MONDO:0007374
    label: Sickle cell disease (SCD)
  - id: MAXO:0000457
    label: pain management
  - id: HP:0001903
    label: anemia
  - id: CHEBI:44423
    label: hydroxyurea
  - id: CHEBI:18050
    label: L-glutamine
  - id: MAXO:0000058
    label: pharmacotherapy
  - id: HP:0100602
    label: preeclampsia
  - id: HP:0001622
    label: preterm delivery
  - id: HP:0001511
    label: intrauterine growth restriction
  - id: CHEBI:50858
    label: corticosteroids
  - id: HP:0001907
    label: thromboembolism
  - id: MAXO:0000503
    label: Mechanical ventilation
  - id: MONDO:0011382
    label: Sickle Cell Disease
  - id: MAXO:0001001
    label: Gene therapies
  - id: HP:0025322
    label: VOD
  - id: CHEBI:82557
    label: Treosulfan
  - id: MAXO:0000750
    label: conditioning regimen
  - id: MONDO:0007885
    label: Osteonecrosis of the femoral head (AVNFH)
  - id: HP:0012531
    label: Pain
  - id: HP:0000969
    label: Oedema
  - id: MONDO:0018660
    label: hemophilia
  - id: HP:0012532
    label: Chronic pain
  - id: CHEBI:3216
    label: Buprenorphine
  - id: MAXO:0000747
    label: Hematopoietic stem cell transplantation
  - id: HP:0100543
    label: cognitive dysfunction
  - id: HP:0000739
    label: anxiety
  - id: CHEBI:50131
    label: Decitabine
  - id: CHEBI:29548
    label: Cytidine deaminase (CDA)
  - id: MONDO:0009693
    label: Multiple Myeloma
  - id: CHEBI:145536
    label: Motixafortide
  - id: MAXO:0000601
    label: Dialysis
  - id: HP:0000083
    label: Kidney failure
  - id: MONDO:0100096
    label: COVID-19
  - id: MAXO:0001017
    label: vaccination
  - id: CHEBI:28901
    label: busulfan
  - id: CHEBI:9570
    label: thiotepa
  - id: MAXO:0000952
    label: Hydration therapy
  - id: HP:0006775
    label: Myeloma
  - id: MAXO:0000756
    label: blood transfusions
  - id: MONDO:0005570
    label: Hematologic diseases
  - id: HP:0007760
    label: Sickle cell disease (SCD)
  - id: MAXO:0010203
    label: echocardiography
  - id: CHEBI:31980
    label: Definity
  - id: MAXO:0000149
    label: Hematopoietic stem cell transplantation (HCT)
  - id: HP:0001297
    label: stroke
  - id: CHEBI:6716
    label: Depot medroxyprogesterone acetate
  - id: CHEBI:50114
    label: Estrogen
  - id: CHEBI:59826
    label: Progestin
  - id: MONDO:0005161
    label: Human papillomavirus (HPV)
  - id: MAXO:0000759
    label: HPV vaccination
  - id: MAXO:0000194
    label: opioid therapy
  - id: MAXO:0000882
    label: behavioral modification
  - id: MAXO:0001298
    label: therapy
  - id: MAXO:0010041
    label: skin grafting
  - id: MONDO:0044348
    label: Hemoglobinopathies
  - id: HP:0002092
    label: Pulmonary hypertension
  - id: MAXO:0000573
    label: use of assisted reproductive technologies (ART)
  - id: HP:0000044
    label: hypogonadotropic hypogonadism (HH)
  - id: HP:0009800
    label: gestational diabetes mellitus
  - id: HP:0011891
    label: post-partum haemorrhage
  - id: HP:0002617
    label: Vasculopathy
  - id: CHEBI:15365
    label: Aspirin
  - id: MAXO:0000068
    label: Transplantation
  - id: HP:0004870
    label: Chronic hemolytic anemia
  - id: CHEBI:27690
    label: Acetazolamide
  - id: MAXO:0001175
    label: liver transplantation
  - id: HP:0000952
    label: jaundice
  - id: MAXO:0000602
    label: Hemodialysis
  - id: MONDO:0002492
    label: Acute kidney injury
  - id: HP:0002240
    label: Hepatomegaly
  - id: HP:0001744
    label: Splenomegaly
  - id: HP:0000790
    label: Hematuria
  - id: HP:0001919
    label: Acute kidney injury
  - id: HP:0001735
    label: acute pancreatitis
  - id: HP:0001953
    label: diabetic ketoacidosis
  - id: HP:0001873
    label: thrombocytopenia
  - id: HP:0001882
    label: leukopenia
  - id: HP:0003077
    label: hyperlipidemia
  - id: HP:0002155
    label: hypertriglyceridemia
  - id: CHEBI:9168
    label: Sirolimus
  - id: CHEBI:68554
    label: Deferiprone (L1)
  - id: CHEBI:4356
    label: Deferoxamine
  - id: MONDO:0010122
    label: congenital TTP
  - id: HP:0000789
    label: Infertility
  - id: HP:0011134
    label: low-grade fever
  - id: HP:0001974
    label: leukocytosis
  - id: CHEBI:28001
    label: vancomycin
  - id: CHEBI:17833
    label: gentamycin
  - id: CHEBI:33281
    label: antibiotics
  - id: HP:0003774
    label: End-stage renal disease (ESRD)
  - id: HP:0000716
    label: Depression
  - id: MAXO:0000950
    label: supportive care
  - id: HP:0003074
    label: Hyperglycemia
  - id: MONDO:0004981
    label: Atrial Fibrillation
  - id: HP:0005110
    label: Atrial Fibrillation
